Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0015300 Exon-Exon chr12:120600651-120602299 chr12:120162847-120164495 475 nt 0.5853
hsa_GCN1L1_0015400 Exon-Exon chr12:120600651-120602525 chr12:120162847-120164721 551 nt 0.5717
hsa_GCN1L1_0015500 Exon-Exon chr12:120600651-120608125 chr12:120162847-120170321 797 nt 0.5571
hsa_GCN1L1_0015600 Exon-Exon chr12:120600651-120611630 chr12:120162847-120173826 971 nt 0.5489
hsa_GCN1L1_0015700 Exon-Exon chr12:120600651-120614020 chr12:120162847-120176217 1325 nt 0.5494
hsa_GCN1L1_0015900 Exon-Exon chr12:120600874-120602525 chr12:120163070-120164721 426 nt 0.5845
hsa_GCN1L1_0016000 Exon-Exon chr12:120600874-120608125 chr12:120163070-120170321 672 nt 0.5625
hsa_GCN1L1_0016100 Exon-Exon chr12:120600874-120611630 chr12:120163070-120173826 846 nt 0.5520
hsa_GCN1L1_0016200 Exon-Exon chr12:120600874-120614020 chr12:120163070-120176217 1200 nt 0.5517
hsa_GCN1L1_0016300 Exon-Exon chr12:120600874-120615358 chr12:120163070-120177555 1309 nt 0.5447
Showing 111 to 120 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].